These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19397398)

  • 1. Apical interactions of HIV type 1 with polarized HEC-1 cell monolayer modulate R5-HIV type 1 spread by submucosal macrophages.
    Saïdi H; Magri G; Carbonneil C; Bouhlal H; Hocini H; Belec L
    AIDS Res Hum Retroviruses; 2009 May; 25(5):497-509. PubMed ID: 19397398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R5- and X4-HIV-1 use differentially the endometrial epithelial cells HEC-1A to ensure their own spread: implication for mechanisms of sexual transmission.
    Saïdi H; Magri G; Nasreddine N; Réquena M; Bélec L
    Virology; 2007 Feb; 358(1):55-68. PubMed ID: 16934308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma-activated monocytes weakly produce HIV-1 but induce the recruitment of HIV-sensitive T cells and enhance the viral production by these recruited T cells.
    Saïdi H; Magri G; Carbonneil C; Nasreddine N; Réquena M; Bélec L
    J Leukoc Biol; 2007 Mar; 81(3):642-53. PubMed ID: 16971466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.
    Schmitt N; Nugeyre MT; Scott-Algara D; Cumont MC; Barré-Sinoussi F; Pancino G; Israël N
    AIDS; 2006 Feb; 20(4):533-42. PubMed ID: 16470117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV-2 genotype and the HIV-1 syncytium-inducing phenotype are associated with a lower virus replication in dendritic cells.
    Vanham G; van Tendeloo V; Willems B; Penne L; Kestens L; Beirnaert E; Fransen K; Heyndrickx L; Zhong P; Davis D; Berneman Z; van Der Groen G; Van Bockstaele D
    J Med Virol; 2000 Mar; 60(3):300-12. PubMed ID: 10630963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential in vitro inhibitory activity against HIV-1 of alpha-(1-3)- and alpha-(1-6)-D-mannose specific plant lectins: implication for microbicide development.
    Saïdi H; Nasreddine N; Jenabian MA; Lecerf M; Schols D; Krief C; Balzarini J; Bélec L
    J Transl Med; 2007 Jun; 5():28. PubMed ID: 17565674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages.
    Kedzierska K; Crowe SM; Turville S; Cunningham AL
    Rev Med Virol; 2003; 13(1):39-56. PubMed ID: 12516061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 pathogenesis differs in rectosigmoid and tonsillar tissues infected ex vivo with CCR5- and CXCR4-tropic HIV-1.
    Grivel JC; Elliott J; Lisco A; Biancotto A; Condack C; Shattock RJ; McGowan I; Margolis L; Anton P
    AIDS; 2007 Jun; 21(10):1263-72. PubMed ID: 17545702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
    Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
    J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential susceptibility of naïve, central memory and effector memory T cells to dendritic cell-mediated HIV-1 transmission.
    Groot F; van Capel TM; Schuitemaker J; Berkhout B; de Jong EC
    Retrovirology; 2006 Aug; 3():52. PubMed ID: 16916447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1.
    Moriuchi M; Moriuchi H; Turner W; Fauci AS
    J Clin Invest; 1998 Oct; 102(8):1540-50. PubMed ID: 9788967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
    Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
    Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncoupling coreceptor usage of human immunodeficiency virus type 1 (HIV-1) from macrophage tropism reveals biological properties of CCR5-restricted HIV-1 isolates from patients with acquired immunodeficiency syndrome.
    Gray L; Sterjovski J; Churchill M; Ellery P; Nasr N; Lewin SR; Crowe SM; Wesselingh SL; Cunningham AL; Gorry PR
    Virology; 2005 Jul; 337(2):384-98. PubMed ID: 15916792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of CCR5-tropic human immunodeficiency virus-1 transfer from macrophages towards T cells under interleukin-4/interleukin-13 microenvironment.
    Saïdi H; Carbonneil C; Magri G; Eslahpazir J; Sekaly RP; Bélec L
    Hum Immunol; 2010 Jan; 71(1):1-13. PubMed ID: 19706316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interactions in human lymphoid tissue: Human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation.
    Lisco A; Grivel JC; Biancotto A; Vanpouille C; Origgi F; Malnati MS; Schols D; Lusso P; Margolis LB
    J Virol; 2007 Jan; 81(2):708-17. PubMed ID: 17065205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro.
    Lorin C; Saidi H; Belaid A; Zairi A; Baleux F; Hocini H; Bélec L; Hani K; Tangy F
    Virology; 2005 Apr; 334(2):264-75. PubMed ID: 15780876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of macrophage-tropic HIV-1 by breast-milk macrophages via DC-SIGN.
    Satomi M; Shimizu M; Shinya E; Watari E; Owaki A; Hidaka C; Ichikawa M; Takeshita T; Takahashi H
    J Infect Dis; 2005 Jan; 191(2):174-81. PubMed ID: 15609226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
    Guan Y; Abdelwahab S; Kamin-Lewis R; DeVico AL; Lewis GK
    PLoS One; 2008; 3(10):e3481. PubMed ID: 18941536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of anti-HIV-1 activity of RANTES by heparan sulfate proteoglycans.
    Oravecz T; Pall M; Wang J; Roderiquez G; Ditto M; Norcross MA
    J Immunol; 1997 Nov; 159(9):4587-92. PubMed ID: 9379060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.